Reboxetine Tablets USP 2mg


Reboxetine Tablets USP 2mg
Reboxetine Tablets USP 4mg

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

  1. What Reboxetine is and what it is used for
  2. What you need to know before you take Reboxetine
  3. How to take Reboxetine
  4. Possible side effects
  5. How to store Reboxetine
  6. Contents of the pack and other information
  7. What Reboxetine is and what it is used for

The active substance in Reboxetineis reboxetine which is part of a group of medicines called antidepressants. Reboxetine is used in the acute treatment of depressive illness / major depression as well as for maintaining the improvement of your symptoms when you have initially responded to treatment with reboxetine.

  • What you need to know before you take Reboxetine

Do not take Reboxetine

  • If you are allergic to Reboxetine or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Reboxetin

  • to suffer from convulsions or epilepsy. Treatment with reboxetine should be stopped if seizures occur.
    • have any signs of urinary problems, enlarged prostate or a history of heart problems.
    • are taking medicines to lower your blood pressure.
    • have liver or kidney problems. Your doctor may need to adjust your dosage.
    • are taking any other medicine for depression such as MAO inhibitors, tricyclics, nefazodone, SSRIs (such as fluvoxamine) or lithium.
    • are taking other MAO inhibitors such as linezolid (an antibiotic) or methylene blue (see section ?Other medicines and Reboxetine?).
    • ever had episodes of mania (overactive behaviour or thoughts).
    • have eye problems, such as certain kinds of glaucoma (increased pressure in the eye).

Thoughts of suicide and worsening of your depression:

If you are depressed you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.

You may be more likely to think like this:

– If you have previously had thoughts about killing or harming yourself.

– If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behavior in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

You may find it helpful to tell a relative or close friend that you are depressed, and ask them to read this leaflet. You might ask them to tell you if they think your depression is getting worse, or if they are worried about changes in your behaviour.

Children and adolescents

Reboxetine should not usually be used in children and adolescents less than 18 years old. Patients under 18 have an increased risk of undesirable effects, such as suicide attempt, suicidal thoughts and hostility (mainly aggressiveness, oppositional behaviour and anger) when they are treated with this class of medicines.

Nevertheless, it is possible that your doctor decides to prescribe Reboxetine to a patient under 18 if it is in the patient’s interest. If your doctor has prescribed Reboxetine to a patient less than 18 years old and you want to discuss this, please contact him/her.

Furthermore, if any of the symptoms listed above appear or worsen when a patient under 18 is taking Reboxetine, you should inform your doctor.

Also, the long-term safety of Reboxetine in regard to growth, maturation and cognitive and behavioural development in this age group has not yet been demonstrated.

Other medicines and Reboxetine

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Reboxetine may affect or be affected by other medicines. These include:

  • Certain antifungals, e.g. ketoconazole
    • Certain antibiotics, e.g. erythromycin, rifampicin
    • Medicines called ergot derivatives used to treat migraine or Parkinson?s disease
    • Certain antidepressants called MAO inhibitors, tricyclics, nefazodone, SSRIs (such as fluvoxamine) or lithium
    • Other MAO inhibitors such as linezolid (an antibiotic) and methylene blue (used to treat high levels of methaemoglobin in the blood)
    • Any potassium-losing diuretics (medicines for eliminating water), e.g. thiazides
    • Medicines used to treat epilepsy e.g. phenobarbital, carbamazepine and phenytoin
    • Herbal medicines containing St. John`s Wort (Hypericum perforatum)

Your doctor will tell you whether you can take Reboxetine with other medicines. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, herbal medicines, as well as vitamins and minerals.

Reboxetine with food and drink

Reboxetine can be taken with or without food.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


There are no adequate experiences from the use of Reboxetine in pregnant women. Do not take Reboxetine if you are pregnant, unless your doctor considers it absolutely necessary, following a careful clinical risk/benefit consideration. Tell your doctor immediately if you are pregnant or are planning to become pregnant.


Reboxetine passes into the breast milk in small amounts. There is a risk of a potential effect on the baby.

Therefore, you should discuss the matter with your doctor and he/she will decide whether you should stop breast-feeding or stop the therapy with Reboxetine.

Driving and using machines

Caution is recommended when driving or using machines.

You should not drive or operate machinery until you know you are not affected (i.e. feel drowsy) by Reboxetine, and that it is safe to do so.

  • How to take Reboxetine

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • The recommended dose in adults is 8 mg a day (one 4 mg tablet twice a day). Based on how you respond to the medicine, after 3 to 4 weeks your doctor may tell you to take up to 10 mg per day if necessary. The maximum daily dose should not exceed 12 mg.
    • In patients with poor kidney or liver function, the starting dose is 4 mg per day. This may be increased depending on the individual response.
    • The use of Reboxetine 4 mg tablets cannot be recommended for elderly patients.
    • Reboxetine should not be used in children and adolescents under 18 years.

The tablets should be taken in two divided doses, one dose in the morning and one in the evening. You should swallow your tablet with a glass of water. The tablet can be divided into equal doses. Do not chew the tablet.

To help you remember to take Reboxetine, you may find it easier to take your tablets at the same time every day.

Like other drugs, Reboxetine will not relieve your symptoms immediately. You should start to feel better within a few weeks.

It is important that you continue to take your tablets, even though you feel better until your doctor advises you to stop. Please be patient, if you stop taking your tablets too early, your symptoms might come back.

If you take more Reboxetine than you should

You should never take more tablets than your doctor recommends. If you take too many tablets, contact your doctor or local hospital immediately. If you take more Reboxetine than you should, you may experience symptoms of overdose including low blood pressure, anxiety and hypertension.

If you forget to take Reboxetine

If you forget to take Reboxetine, take your next dose at the normal time. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Reboxetine

You should not stop your medicine without talking to your doctor, as your symptoms may come back.

There have been a few reports of withdrawal symptoms including headache, dizziness, nervousness and nausea (feeling sick) when patients stopped treatment with Reboxetine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

  • Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. With Reboxetine most side effects are mild and usually go away after the first few weeks of treatment.

If any of the side effects below gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Very common side effects (more than one in 10 patients)

  • Difficulties in sleep (insomnia)
    • Dizziness
    • Dry mouth
    • Constipation
    • Nausea (feeling sick)
    • Sweating

Common side effects (less than one in 10 patients)

  • Headache
    • Lack or loss of appetite
    • Agitation, anxiety
    • Paraesthesia (pins and needles), inability to sit or stand still, altered taste sensation
    • Lack of visual focus
    • Increased heart rate, palpitation (heart pounding)
    • Widened blood vessels, fall in blood pressure when standing up, increased blood pressure
    • Vomiting
    • Rash
    • A sensation of incomplete emptying or slowed emptying of the bladder, urinary infection, painful
  • urination, inability to completely empty the bladder
  • Erectile dysfunction (impotence), ejaculatory pain or ejaculatory delay
  • Chills

Uncommon side effects (between 1 and 10 out of 1000 patients)

  • Dilated pupils
    • Spinning sensation

Rare side effects (between 1 and 10 out of 10000 patients)

  • Glaucoma (a condition resulting in increased pressure in the eye)
  • After marketing Reboxetine, the following side effects have been reported:
  • Hyponatremia (very low levels of sodium in the blood)
  • Aggressive behaviour, hallucination
  • Suicidal ideation, Suicidal behaviour

Cases of suicidal ideation and suicidal behaviours have been reported during reboxetine therapy or early after treatment discontinuation (see section 2 ?Warnings and precautions?)

  • Cold extremities, Raynaud?s phenomenon (poor blood circulation to the extremities usually in the toes and fingers but could also affect nose and ears, the skin turns pale and becomes cold and numb)
    • Allergic skin inflammation
    • Testicular pain
    • Irritability
    • Increased pressure in the eye

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

  • How to store Reboxetine

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton or the bottle. The expiry date refers to the last day of that month.

Do not store Reboxetine above 25?C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

  • Contents of the pack and other information

What Reboxetine contains:

The active substance is reboxetine.

  • Each tablet contains 4 mg of reboxetine

The other ingredients are:

  • Cellulose Microcrystalline, Calcium Hydrogen Phosphate Dihydrate, Crospovidone, Silica Colloidal Hydrated and Magnesium Stearate.

What Reboxetine looks like and contents of the pack:

Reboxetine is white, round, convex tablets with a breakline. A ?P? is marked on the left side of the breakline and a ?U? is marked on the right side. The side opposite the breakline is marked ?7671?. The tablet can be divided into equal doses.

Reboxetine is available in 10, 20, 50, 60, 100, 120, and 180 tablets in blisters packs, 60 tablets in glass bottles, multipacks of 3×60, 5×60 and 10×60 tablets in blisters; and 3×60, 5×60 and 10×60 tablets in glass bottles.

Not all pack sizes may be marketed.

Manufactured in India by:
Unit No. 214, Old Bake House,
Bake House Lane, Fort,
at: Ahmedabad- Gujarat, INDIA.
Ho.NO. +91 8448 444 095
Toll Free Phone: (1800-222-434 / 1800-222-825)